956541241	956541241	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
29831803	29831803	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6128114	6128114	CD	B-NP	O
|	|	CC	I-NP	O
11/23/2004	11/23/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
OSTEOMYELITIS	OSTEOMYELITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/22/2004	5/22/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2004	10/10/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CORTEZ	CORTEZ	NNP	B-NP	O
DERICK	DERICK	NNP	I-NP	O
SADLIER	SADLIER	NNP	I-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
9/14/04	9/14/04	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
plantar	plantar	NN	I-NP	O
surface	surface	NN	I-NP	O
neurotrophic	neurotrophic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long-standing	long-standing	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
and	and	CC	O	O
slight	slight	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
thus	thus	RB	B-ADVP	O
far	far	RB	I-ADVP	O
by	by	IN	B-PP	O
podiatric	podiatric	JJ	B-NP	O
debridements	debridement	NNS	I-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
past	past	NN	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
before	before	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
recent	recent	JJ	B-NP	O
eye	eye	NN	I-NP	O
surgery	surgery	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
origin	origin	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
pancreatic	pancreatic	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
1968	1968	CD	B-NP	O
most	most	RBS	B-ADJP	O
likely	likely	JJ	I-ADJP	O
for	for	IN	B-PP	O
phlegmon	phlegmon	NN	B-NP	O
or	or	CC	O	O
some	some	DT	B-NP	O
sort	sort	NN	I-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
9/14/04	9/14/04	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
plantar	plantar	NN	I-NP	O
surface	surface	NN	I-NP	O
neurotrophic	neurotrophic	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
recent	recent	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ulcer	ulcer	NN	I-NP	O
came	come	VBD	B-VP	O
about	about	RP	B-PRT	O
after	after	IN	B-PP	O
some	some	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
podiatrist	podiatrist	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
outpatient	outpatient	NN	B-NP	O
MRI	MRI	NN	I-NP	O
revealing	reveal	VBG	B-VP	O
osteo	osteo	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
metatarsal	metatarsal	JJ	I-NP	O
head	head	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
metatarsal	metatarsal	JJ	I-NP	O
shaft	shaft	NN	I-NP	O
,	,	,	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Egan	Egan	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
after	after	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
101.3	101.3	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
low-grade	low-grade	JJ	I-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
99.7	99.7	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
144/67	144/67	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
saturating	saturate	VBG	I-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Humalog	Humalog	NNP	B-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Humalog	Humalog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Zocor	Zocor	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

TriCor	TriCor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Eyedrops	Eyedrop	NNS	B-NP	O
prednisolone	prednisolone	NN	I-NP	O
and	and	CC	I-NP	O
atropine	atropine	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-NP	O
findings	finding	NNS	I-NP	O
and/or	and/or	CC	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
clear	clear	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
2/6	2/6	CD	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
and	and	CC	O	O
otherwise	otherwise	RB	B-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
obese	obese	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
back	back	RB	B-VP	O
revealed	reveal	VBD	I-VP	O
no	no	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
metatarsal	metatarsal	JJ	I-NP	O
distal	distal	JJ	I-NP	O
heads	head	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
somewhat	somewhat	RB	I-NP	O
cyanotic	cyanotic	JJ	I-NP	O
appearing	appear	VBG	I-NP	O
and	and	CC	O	O
somewhat	somewhat	RB	B-ADJP	O
edematous	edematous	JJ	I-ADJP	O
and	and	CC	O	O
swollen	swell	VBN	B-VP	O
fifth	fifth	JJ	B-NP	O
right	right	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
sensation	sensation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
feet	foot	NNS	I-NP	O
up	up	RB	B-PP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
shin	shin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
known	know	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
drug	drug	NN	B-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
significant	significant	JJ	I-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
was	be	VBD	B-VP	O
4.3	4.3	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
38	38	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
was	be	VBD	B-VP	O
3.2	3.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
was	be	VBD	B-VP	O
187	187	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
12.6	12.6	CD	B-NP	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
was	be	VBD	B-VP	O
27.8	27.8	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
service	service	NN	I-NP	O
under	under	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tosco	Tosco	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
103.2	103.2	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
an	an	DT	B-NP	O
amputation	amputation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
and	and	CC	I-NP	O
fourth	fourth	JJ	I-NP	O
toe	toe	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
metatarsal	metatarsal	JJ	B-NP	O
heads	head	NNS	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
the	the	DT	B-NP	O
infected	infected	JJ	I-NP	O
bone	bone	NN	I-NP	O
and	and	CC	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
bumped	bump	VBN	B-VP	O
before	before	IN	B-PP	O
his	his	PRP$	B-NP	O
operation	operation	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
59	59	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
occurred	occur	VBD	B-VP	O
coincidentally	coincidentally	RB	B-ADVP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
MRIs	MRI	NNS	I-NP	O
of	of	IN	B-PP	O
is	be	VBZ	B-VP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
vascular	vascular	JJ	I-NP	O
supply	supply	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
contrast	contrast	NN	B-NP	O
dye	dye	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
,	,	,	O	O
this	this	DT	B-NP	O
dye	dye	NN	I-NP	O
was	be	VBD	B-VP	O
gadolinium	gadolinium	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
sued	sue	VBN	I-VP	O
commonly	commonly	RB	B-ADVP	O
for	for	IN	B-PP	O
MRA	MRA	NN	B-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
usually	usually	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
soft	soft	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
toxicities	toxicity	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
and	and	CC	I-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
and	and	CC	O	O
nonhealing	nonhealing	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
debridement	debridement	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
refer	refer	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Guemmer	Guemmer	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
problems	problem	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
adequate	adequate	JJ	B-ADJP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
lab	lab	NN	I-NP	O
checkup	checkup	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
see	see	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
4.9	4.9	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
61	61	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
viewed	view	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
serial	serial	JJ	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
checks	check	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	following	NN	I-NP	O
,	,	,	I-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
69	69	CD	B-NP	O
for	for	IN	B-PP	O
BUN	BUN	NN	B-NP	B-protein
and	and	CC	O	O
5.2	5.2	CD	B-NP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
6.5	6.5	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
input	input	NN	I-NP	O
as	as	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	I-NP	O
postoperative	postoperative	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
level	level	NN	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
30.8	30.8	CD	B-NP	O
.	.	.	O	O

FENa	FENa	NN	B-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
0.74	0.74	CD	B-NP	O
%	%	NN	I-NP	O
FENa	FENa	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
rechecked	rechecke	VBN	I-VP	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
FENa	FENa	NN	I-NP	O
of	of	IN	B-PP	O
0.97	0.97	CD	B-NP	O
%	%	NN	I-NP	O
both	both	CC	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
indicated	indicate	VBD	B-VP	O
prerenal	prerenal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
team	team	NN	I-NP	O
also	also	RB	B-ADVP	O
advised	advise	VBD	B-VP	O
checking	check	VBG	I-VP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
anemia	anemia	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
other	other	JJ	B-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
some	some	DT	B-NP	O
are	be	VBP	B-VP	O
currently	currently	RB	I-VP	O
pending	pende	VBG	I-VP	O
regarding	regard	VBG	B-PP	O
the	the	DT	B-NP	O
C3-C4	C3-C4	NN	I-NP	B-DNA
and	and	CC	I-NP	O
anti-GMB	anti-GMB	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
despite	despite	IN	B-PP	O
advanced	advanced	JJ	B-NP	O
management	management	NN	I-NP	O
including	include	VBG	B-PP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
resuscitation	resuscitation	NN	I-NP	O
,	,	,	O	O
fluid	fluid	JJ	B-NP	O
volume	volume	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
boluses	bolus	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
94	94	CD	B-NP	O
and	and	CC	I-NP	O
8.3	8.3	CD	I-NP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-NP	O
postoperative	postoperative	JJ	I-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
began	begin	VBD	B-VP	O
resolving	resolve	VBG	I-VP	O
that	that	IN	B-SBAR	O
BUN	BUN	NN	B-NP	B-protein
of	of	IN	B-PP	O
95	95	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
7.8	7.8	CD	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
hypoglycemic	hypoglycemic	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Lantus	Lantus	NNP	I-NP	O
dose	dose	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
getting	get	VBG	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
summarized	summarize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
team	team	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
his	his	PRP$	B-NP	O
medication	medication	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
now	now	RB	B-VP	O
was	be	VBD	I-VP	O
being	be	VBG	I-VP	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
dysregulation	dysregulation	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
of	of	IN	B-PP	O
367	367	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
,	,	,	O	O
somewhat	somewhat	RB	B-ADJP	O
somnolent	somnolent	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
groggy	groggy	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
service	service	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
summarized	summarize	VBN	I-VP	O
by	by	IN	B-PP	O
them	them	PRP	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
ended	end	VBD	B-VP	O
up	up	RP	B-PRT	O
having	have	VBG	B-VP	O
insulin	insulin	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
clearance	clearance	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
functioning	function	VBG	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
postoperative	postoperative	JJ	I-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
never	never	RB	B-ADVP	O
required	require	VBD	B-VP	O
a	a	DT	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
potassium	potassium	NN	I-NP	O
levels	level	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reached	reach	VBD	B-VP	O
was	be	VBD	B-VP	O
5.6	5.6	CD	B-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
day	day	NN	I-NP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatine	creatine	NN	I-NP	O
of	of	IN	B-PP	O
8.3	8.3	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
kayexalate	kayexalate	NN	B-NP	O
and	and	CC	B-PP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
lines	line	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-VP	O
b.i.d.	b.i.d.	VB	I-VP	O
dosing	dosing	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
holding	hold	VBG	I-VP	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
possible	possible	JJ	I-NP	O
renal	renal	JJ	I-NP	O
toxic	toxic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Doppler	Doppler	NNP	B-NP	O
flow	flow	NN	I-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
parenchyma	parenchyma	NN	I-NP	O
with	with	IN	B-PP	O
somewhat	somewhat	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
renal	renal	JJ	I-NP	O
indices	index	NNS	I-NP	O
indicating	indicate	VBG	B-VP	O
some	some	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
flow	flow	NN	I-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
kidneys	kidney	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
MRA	MRA	NN	I-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
stenosis	stenosis	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
PhosLo	PhosLo	NNP	B-NP	O
and	and	CC	I-NP	O
Ferrlecit	Ferrlecit	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Epogen	Epogen	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
q.	q.	VBP	B-VP	O
week	week	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
complications	complication	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
became	become	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
by	by	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
at	at	IN	B-PP	O
previous	previous	JJ	B-NP	O
doses	dose	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
demonstrated	demonstrate	VBN	B-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
attained	attain	VBN	I-VP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
at	at	IN	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
service	service	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
given	give	VBN	I-VP	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
controlled	control	VBN	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
being	be	VBG	B-VP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
assisted	assist	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
wax	wax	NN	I-NP	O
sponge	sponge	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
open	open	JJ	I-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
4/18/04	4/18/04	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
tolerating	tolerate	VBG	I-VP	O
this	this	DT	B-NP	O
well	well	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
teams	team	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
closely	closely	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
until	until	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
postoperative	postoperative	JJ	I-NP	O
complications	complication	NNS	I-NP	O
and	and	CC	I-NP	O
issues	issue	NNS	I-NP	O
including	include	VBG	B-PP	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
were	be	VBD	B-VP	O
under	under	IN	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
an	an	DT	B-NP	O
operative	operative	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
Still	Still	NNP	I-NP	O
Freedral	Freedral	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
care	care	VB	I-VP	O
for	for	IN	B-PP	O
wax	wax	NN	B-NP	O
sponge	sponge	NN	I-NP	O
excellently	excellently	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ulvan	Ulvan	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
staff	staff	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
management	management	NN	I-NP	O
service	service	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Clint	Clint	NNP	I-NP	O
Holets	Holets	NNP	I-NP	O
,	,	,	O	O
pager	pager	NN	B-NP	O
#	#	#	B-NP	O
596-76	596-76	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
Doppler	Doppler	NNP	I-NP	O
signal	signal	NN	I-NP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
DPs	DP	NNS	B-NP	B-DNA
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
PTs	PT	NNS	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
faintly	faintly	RB	I-NP	O
palpable	palpable	JJ	I-NP	O
right	right	JJ	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
faintly	faintly	RB	B-NP	O
palpable	palpable	JJ	I-NP	O
left	left	JJ	I-NP	O
DP	DP	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
to	to	TO	I-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
temperature	temperature	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
1334	1334	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
give	give	VBP	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Epogen	Epogen	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
delivered	deliver	VBN	B-VP	O
subcuticularly	subcuticularly	RB	B-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
already	already	RB	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
intra	intra	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
give	give	VB	I-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
7/9/04	7/9/04	CD	B-NP	O
or	or	CC	I-NP	O
07	07	CD	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
prednisolone	prednisolone	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
effected	effect	VBN	I-NP	O
eye	eye	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
atropine	atropine	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	O
eye	eye	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
starting	start	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
10/6/04	10/6/04	CD	I-NP	O
and	and	CC	O	O
continuing	continue	VBG	B-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Lispro	Lispro	NN	B-NP	B-protein
6	6	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcuticularly	subcuticularly	RB	B-ADVP	O
q.a.c.	q.a.c.	VBP	B-VP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
eating	eat	VBG	I-VP	O
much	much	RB	B-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
meal	meal	NN	I-NP	O
sitting	sit	VBG	B-VP	O
right	right	NN	B-NP	O
in	in	IN	B-PP	O
front	front	NN	B-NP	O
of	of	IN	B-PP	O
him	him	PRP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
dosage	dosage	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
Lispro	Lispro	JJ	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
paper	paper	NN	I-NP	O
work	work	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
receives	receive	VBZ	B-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
125	125	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
150	150	CD	B-NP	I-DNA
and	and	CC	O	O
onwards	onwards	RB	B-ADVP	O
from	from	IN	B-PP	O
there	there	RB	B-NP	O
3	3	CD	I-NP	O
units	unit	NNS	I-NP	O
for	for	IN	B-PP	O
150	150	CD	B-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
forth	forth	RB	I-ADVP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
give	give	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
half	half	PDT	B-NP	O
his	his	PRP$	I-NP	B-DNA
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
dose	dose	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedtime	bedtime	NN	I-NP	O
if	if	IN	B-SBAR	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
and	and	CC	O	O
recheck	recheck	VB	B-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
TriCor	TriCor	NN	B-NP	O
54	54	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
25	25	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
at	at	IN	B-PP	O
Ing	Ing	NNP	B-NP	O
Mansy	Mansy	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
note	note	VBP	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
report	report	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Dr.	Dr.	NNP	B-NP	O
Knaub	Knaub	NNP	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
paper	paper	NN	I-NP	O
work	work	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wax	wax	NN	I-NP	O
sponge	sponge	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
change	change	VB	I-VP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
please	please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Zaxas	Zaxas	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
longevity	longevity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wax	wax	NN	I-NP	O
sponge	sponge	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Amos	Amos	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Riech	Riech	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinic	clinic	JJ	I-NP	O
number	number	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
service	service	NN	I-NP	O
is	be	VBZ	B-VP	O
7817612	7817612	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-8401296	6-8401296	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
WUERZ	WUERZ	NNP	B-NP	O
,	,	,	O	O
SANDY	SANDY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
COWAN	COWAN	NN	B-NP	O
,	,	,	O	O
WILBUR	WILBUR	NNP	B-NP	O
MIQUEL	MIQUEL	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9146558	9146558	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/9/04	3/9/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/9/04	3/9/04	CD	B-NP	O

